Diversifying Endocrinology Research With Optimized Trials

Endocrine disorders disproportionately affect racial and ethnic minorities in the U.S., with conditions like diabetes being significantly more prevalent in these communities. Despite the clear need for better healthcare solutions, research participation among Black/African American and Hispanic/Latino populations remains critically low, often as low as 10.6%. Improving outcomes for these underserved groups requires a shift towards engaging them more effectively in clinical research.

Elligo Health Research's optimized trial model addresses this by using HIPAA-compliant EHR data and AI-powered analytics to identify and engage diverse patient groups. By conducting virtual and hybrid trials through healthcare-first sites—trusted local healthcare providers that integrate research into their practices—Elligo makes research participation more accessible and appealing. This patient-centric approach not only enhances diversity in clinical trials but also improves overall study execution and outcomes. Discover how Elligo’s optimized trials can revolutionize your endocrinology research and drive meaningful improvements in patient care.